HomeWhat Laws Protect Coronavirus Whistleblowers? Whistleblower Attorneys Publish FAQs for Coronavirus Whistleblowers and Qui Tam relators

What Laws Protect Coronavirus Whistleblowers? Whistleblower Attorneys Publish FAQs for Coronavirus Whistleblowers and Qui Tam relators

Today the whistleblower law firm Kohn, Kohn & Colapinto published a Frequently Asked Questions (FAQs) page regarding the protections afforded to Coronavirus Whistleblowers when reporting fraud and misconduct on public health and safety violations. The firm issued the FAQs in response to the overwhelming need for employees who report health and safety violations related to the Coronavirus crisis to understand what laws protect their right to blow the whistle.

The FAQs explain how whistleblowers can use the highly effective False Claims Act to root out fraud related to the federal funding earmarked to fight the Coronavirus. The False Claims Act covers all programs funded by Medicaid and Medicare. The FAQs also include information on the right of employees to report threats to the public health and safety under other federal and state laws, including laws that permit employees to lawfully report threats to the public health to Congress, Inspectors General, or other “appropriate authorities.”

The whistleblower attorneys at Kohn, Kohn and Colapinto have experience representing employees who successfully sued corrupt contractors under the qui tam provisions of the False Claims Act for violating laws protecting public health safety. As an effort to prevent fraud from compromising the fight against the Coronavirus, its partners drafted the FAQs as a pro bono service to educate healthcare workers, employees of government contractors, and state and federal employees as to their rights.

“In light of the U.S. Government spending billions to fight the Coronavirus, it is imperative to hold fraudsters who seek to profit from the Coronavirus crisis accountable,” said Stephen M. Kohn, a founding partner of the firm, and the Chairman of the Board of Directors of the National Whistleblower Center.

“The Department of Justice must ensure that the False Claims Act and other whistleblower laws are vigorously enforced whenever credible evidence of fraud in public health programs is reported by whistleblowers. The Justice Department must prioritize protecting all federal programs designed to combat the Coronavirus,” Kohn added.

The FAQs cover critical federal and state whistleblower and anti-retaliation laws.

The FAQs include laws and statutes related to:

Fraud in government contracts

Fraud in Medicaid and Medicare programs

Federal and state laws that protect healthcare workers

Protections for Federal Employees

Protections under the First Amendment

Protections for private sector employees

“One would hope that there would be no need for whistleblower protections during a national emergency. But history teaches the opposite. Fraudsters often prey on the weak and take advantage of a crisis,” said Kohn.

Visit the FAQ page: Coronavirus Whistleblowing and Qui Tam: Reporting Fraud and Misconduct on Public Health and Safety Violations

Share This Story, Choose Your Platform!

Latest News & Insights

  • February 27, 2023

    On February 23, Kohn, Kohn & Colapinto (KKC), on behalf of the National Whistleblower Center (NWC), filed an amicus curiae brief in the Supreme Court case U.S. ex rel. Schutte v. SuperValu Inc. Referencing historical materials pulled from the National Archive, the brief argues that the Congressional intent behind the False Claims Act was to hold fraudsters liable based on the ...

  • February 8, 2023

    In the 2022 Fiscal Year (FY 2022), the U.S. Department of Justice (DOJ) recovered only $776 million in False Claims Act (FCA) whistleblower cases in which it intervened, the lowest total since 2004. In contrast, FCA whistleblower cases where the DOJ did not intervene resulted in a record $1.1 billion in recoveries, ...

  • January 24, 2023

    Stephen M. Kohn, Esq. writes for Reuters outlining the massive impact the new AML Whistleblower Improvement Act will have in fighting Russian corruption.

  • December 6, 2022

    On December 6, the U.S. Supreme Court heard arguments in United States, ex rel. Polansky v. Executive Health Resources, Inc. The case concerns the issue of whether or not the U.S. government can dismiss False Claim Act whistleblowers' qui tam suits after initially declining to intervene in them. According to whistleblower attorneys, the case has tremendous implications ...

Subscribe for News & Resources

Receive exclusive updates and news from our firm.